Last reviewed · How we verify

NCT03329287

Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression

Status unknown NA Last updated 1 November 2017
What this trial tests

NA trial testing SCBT in Generalized Anxiety Disorder in 180 participants. Status unknown.

Timeline
1 July 2017
Primary endpoint
30 March 2018
30 June 2018

Quick facts

Lead sponsorShanghai Mental Health Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment180
Start date1 July 2017
Primary completion30 March 2018
Estimated completion30 June 2018
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Shanghai Mental Health Center — full company profile →

Who can join

Adults 18 to 60, any sex, with Generalized Anxiety Disorder or Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial attempts to evaluate the treatment efficacy of Simplified Cognitive Behavioral Therapy (SCBT) and its safety among schizophrenia patients. Half of participants will be randomized to accept SCBT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Generalized Anxiety Disorder

Currently open trials in the same condition.

Other Shanghai Mental Health Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03329287.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing